Cargando…
Pharmacogenetic Guidelines for Psychotropic Drugs: Optimizing Prescriptions in Clinical Practice
The modalities for prescribing a psychotropic (dose and choice of molecule) are currently unsatisfactory, which can lead to a lack of efficacy of the treatment associated with prolonged exposure of the patient to the symptoms of his or her illness and the side effects of the molecule. In order to im...
Autores principales: | Baldacci, Antoine, Saguin, Emeric, Balcerac, Alexander, Mouchabac, Stéphane, Ferreri, Florian, Gaillard, Raphael, Colas, Marie-Dominique, Delacour, Hervé, Bourla, Alexis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674305/ https://www.ncbi.nlm.nih.gov/pubmed/38004520 http://dx.doi.org/10.3390/pharmaceutics15112540 |
Ejemplares similares
-
e-Addictology: An Overview of New Technologies for Assessing and Intervening in Addictive Behaviors
por: Ferreri, Florian, et al.
Publicado: (2018) -
e-PTSD: an overview on how new technologies can improve prediction and assessment of Posttraumatic Stress Disorder (PTSD)
por: Bourla, Alexis, et al.
Publicado: (2018) -
Rapid cycling bipolar disorder: Literature review on pharmacological treatment illustrated by a case report on ketamine
por: Bourla, Alexis, et al.
Publicado: (2022) -
Variability in Motor Threshold during Transcranial Magnetic Stimulation Treatment for Depression: Neurophysiological Implications
por: Bourla, Alexis, et al.
Publicado: (2023) -
Psychiatrists' Attitudes Toward Disruptive New Technologies: Mixed-Methods Study
por: Bourla, Alexis, et al.
Publicado: (2018)